Talecris Biotherapeutics, the billion-dollar biotech firm created in 2005 with the acquisition of Bayer Biological Projects, is launching an annual $1 million research plan to encourage studies of ...
NEW YORK, July 28 (Reuters) - Talecris Biotherapeutics Holdings Corp, whose acquisition by CSL Ltd was blocked by regulators, may be moving toward an initial public offering, according to recent ...
NEW YORK/PHILADELPHIA, June 6 (Reuters) - Spanish healthcare company Grifols is close to a deal to buy Talecris Biotherapeutics , which produces plasma-based protein therapies, sources close to the ...
WASHINGTON, June 8 (Reuters) - Australian blood products group CSL Ltd and smaller U.S. rival Talecris Biotherapeutics Holdings Corp [TLBIO.UL] have terminated their $3.1 billion merger agreement ...
Spanish health care company Grifols SA said Monday it had acquired Talecris Biotherapeutics, based in Research Triangle Park, for $4 billion including net debt. In a statement on its website, Grifols, ...
Talecris Biotherapeutics is going public Tuesday on Wall Street, aiming to raise nearly $900 million in what would be the largest initial public offering of stock this year. Talecris Biotherapeutics ...
Almost a year to the day after Talecris Biotherapeutics called off a $3.1 billion merger with an Australian firm, the RTP-based firm has agreed to be bought by another company. Almost a year to the ...
Here's some good biotech job news for a change: Talecris Biotherapeutics, which recently launched a successful IPO, announced that it will create 259 jobs as it plots the $269 million expansion of its ...